Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Public ClinicalTrials.gov record NCT01532336. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Study identification
- NCT ID
- NCT01532336
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- NovaBay Pharmaceuticals, Inc.
- Industry
- Enrollment
- 500 participants
Conditions and interventions
Conditions
Interventions
- NVC-422 Solution, 0.3% Drug
- NVC-422 Vehicle Solution Drug
Drug
Eligibility (public fields only)
- Age range
- 1 Year and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2012
- Primary completion
- Apr 30, 2014
- Completion
- Jul 31, 2014
- Last update posted
- May 27, 2015
2012 – 2014
United States locations
- U.S. sites
- 24
- U.S. states
- 13
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Glendale | California | 91205 | — |
| Not listed | Los Angeles | California | 90048 | — |
| Not listed | Petaluma | California | 94954 | — |
| Not listed | San Diego | California | 92115 | — |
| Not listed | Fort Myers | Florida | 33901 | — |
| Not listed | Jacksonville Beach | Florida | 32250 | — |
| Not listed | Tampa | Florida | 33603 | — |
| Not listed | Albany | Georgia | 31701 | — |
| Not listed | Kailua | Hawaii | 96734 | — |
| Not listed | Glenview | Illinois | 60026 | — |
| Not listed | Peoria | Illinois | 61615 | — |
| Not listed | Shawnee Mission | Kansas | 66204 | — |
| Not listed | Hazard | Kentucky | 41701 | — |
| Not listed | Winchester | Massachusetts | 01890 | — |
| Not listed | Kansas City | Missouri | 64154 | — |
| Not listed | St Louis | Missouri | 63131 | — |
| Not listed | Hicksville | New York | 11801 | — |
| Not listed | Rockville Centre | New York | 11570 | — |
| Not listed | Asheville | North Carolina | 28803 | — |
| Not listed | High Point | North Carolina | 27262 | — |
| Not listed | Winston-Salem | North Carolina | 27101 | — |
| Not listed | Pittsburgh | Pennsylvania | 15206 | — |
| Not listed | Charleston | South Carolina | 29414 | — |
| Not listed | Spartanburg | South Carolina | 29306 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 34 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01532336, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 27, 2015 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01532336 live on ClinicalTrials.gov.